REFERENCES
- Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol. Dial. Transplant 1999; 14: 1732–1738, [INFOTRIEVE], [CSA]
- Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899–1911, [INFOTRIEVE], [CSA], [CROSSREF]
- Flanigan MJ, Frankenfield DL, Prowant BF, Bailie GR, Frederick PR, Rocco MV. Nutritional markers during peritoneal dialysis: data from the 1998 Peritoneal Dialysis Core Indicators Study. Perit. Dial. Int 2001; 21: 345–354, [INFOTRIEVE], [CSA]
- Zoccali C, Benedetto FA, Maas R, et al. CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J. Am. Soc. Nephrol 2002; 13: 490–496, [INFOTRIEVE], [CSA], [CROSSREF]
- Nube MJ. The acute phase response in chronic haemodialysis patients: a marker of cardiovascular disease?. Nephrol. Dial. Transplant 2002; 17: 19–23, [INFOTRIEVE], [CSA]
- Bergström J, Heimburger O, Lindholm B, Qureshi AR. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients. J. Am. Soc. Nephrol 1995; 6: 573, [CSA]
- Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648–658, [INFOTRIEVE], [CSA], [CROSSREF]
- Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol. Dial. Transplant 1999; 14: 1956–1960, [INFOTRIEVE], [CSA], [CROSSREF]
- Noh H, Lee SW, Kang SW, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int 1998; 18: 387–394, [INFOTRIEVE], [CSA]
- Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection—long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol. Dial. Transplant 2001; 16: 809–815, [INFOTRIEVE], [CSA], [CROSSREF]
- Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant 2000; 15: 953–960, [INFOTRIEVE], [CSA], [CROSSREF]
- Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit. Dial. Int 2001; 21: 157–162, [CSA]
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem 1972; 18: 499–502, [INFOTRIEVE], [CSA]
- Fermo I, Arcelloni C, Mazzola G, D'Angelo A, Paroni R. High-performance liquid chromatographic method for measuring total plasma homocysteine levels. J. Chromatogr. B Biomed. Sci. Appl 1998; 20: 31–36, [CSA], [CROSSREF]
- Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971–1990). Kidney Int 1993; 43: 404–409, [INFOTRIEVE], [CSA]
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis 1998; 32: 112–119, [CSA]
- Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998; 54: 245–254, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am. J. Kidney Dis 1990; 15: 458–482, [INFOTRIEVE], [CSA]
- Marckmann P. Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin. Nephrol 1988; 29: 75–78, [INFOTRIEVE], [CSA]
- Bergstrom J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?. Kidney Int 1993; 40: 39–50, [CSA]
- Cianciaruso B, Brunori G, Kopple JD, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am. J. Kidney Dis 1995; 26: 475–486, [INFOTRIEVE], [CSA]
- Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773–782, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kim H, Bologa R, Parker T, et al. Serum IL-6 as an indicator of survival outcome in CAPD patients (Abstract). J. Am. Soc. Nephrol 1999; 10: 1248, [CSA]
- Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients. Am. J. Kidney Dis 1997; 30: 923–927, [INFOTRIEVE], [CSA]
- Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit. Dial. Int 1996; 16: 158–162, [INFOTRIEVE], [CSA]
- Takahashi T, Kubota M, Nakamura T, Ebihara I, Koide H. Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Ren. Fail 2000; 22: 345–354, [INFOTRIEVE], [CSA], [CROSSREF]
- Mitchell JRA, Schwartz JC. Relationship between arterial disease in different sites. A study of the aorta and coronary, carotid and iliac arteries. BMJ 1962; 5288: 1293–1301, [INFOTRIEVE], [CSA]
- Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med 1998; 128: 262–269, [INFOTRIEVE], [CSA]
- Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J. Hypertens 2000; 18: 1207–1213, [INFOTRIEVE], [CSA], [CROSSREF]
- Heinecke JW, Rosen H, Suzuki LA, Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem 1987; 262: 10098–10103, [INFOTRIEVE], [CSA]
- Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA 1994; 91: 6369–6373, [INFOTRIEVE], [CSA], [CROSSREF]
- Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest 1991; 88: 1906–1914, [INFOTRIEVE], [CSA]
- Rigatto C, Parfrey PS. Homocysteine and cardiovascular risk in dialysis patients. Perit. Dial. Int 2000; 20: 167–168, [PUBMED], [INFOTRIEVE], [CSA]
- Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr. Opin. Nephrol. Hypertens 2000; 9: 621–630, [INFOTRIEVE], [CSA]
- Lim PS, Hung WR, Wei YH. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron 2001; 87: 249–256, [INFOTRIEVE], [CSA], [CROSSREF]
- Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997; 61: 1205–1215, [INFOTRIEVE], [CSA], [CROSSREF]
- Moustapha A, Gupta A, Robinson K, et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999; 55: 1470–1475, [INFOTRIEVE], [CSA], [CROSSREF]
- Mallamaci F, Zoccali C, Tripepi G, et al. Creed investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609–614, [INFOTRIEVE], [CSA], [CROSSREF]
- Libetta C, Villa G, Pirrelli S, et al. Homocysteine plasma levels correlate with intimal carotid artery thickness in hemodialysis patients. Nephrol. Dial. Transplant 2001; 16: 2444–2445, [INFOTRIEVE], [CSA], [CROSSREF]
- Suliman ME, Stenvinkel P, Heimburger O, Barany P, Lindholm B, Bergstrom J. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. Am. J. Kidney Dis 2002; 40: 480–488, [INFOTRIEVE], [CSA], [CROSSREF]
- Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J. Am. Soc. Nephrol 2004; 15: 442–453, [INFOTRIEVE], [CSA], [CROSSREF]
- Suliman ME, Qureshi AR, Barany P, et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 2000; 57(4)1727–1735, [INFOTRIEVE], [CSA], [CROSSREF]